Abeona Therapeutics Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 4.35 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 248.75M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.
Details
| Name | Abeona Therapeutics Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 226 |
| Founded | 1974 |
| Ipo Date | 1980-09-19 |
| Ceo | Vishwas Seshadri |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US00289Y2063 |
| Cusip | 00289Y206 |
| Cik | 0000318306 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Dr. Vishwas Seshadri M.B.A., Ph.D. | President, Chief Executive Officer and Director |
| Joseph Walter Vazzano CPA | Chief Financial Officer |
| Dr. Brendan M. O'Malley J.D., Ph.D. | Chief Legal Officer |
| Brian Kevany Ph.D. | Chief Technical and Scientific Officer |
| Gregory Gin | Vice President of Investor Relations and Corporate Communications |
| Gianine Esposito | Senior Vice President and Chief People Officer |
| Jon Voss | Vice President and Head of Quality |
| Dr. Madhav Vasanthavada M.B.A., Ph.D. | SVice President, Chief Commercial Officer and Head of Business Development |
| Carl Denny | Senior Vice President of Regulatory Affairs |
| Megan Callan | Vice President and Head of Quality |
Contact
| Address | 6555 Carnegie Avenue, 4th Floor, Cleveland, Ohio 44103, United States |
| Phone | 646 813 4701 |
| Website | https://www.abeonatherapeutics.com |